NCT01645280 / 2011-001122-18: A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy |
|
|
| Completed | 2 | 274 | US, Europe, RoW | Placebo + methotrexate (MTX) (Group 1), Ustekinumab + MTX (Group 2), Ustekinumab + MTX (Group 3), CNTO 1959 + MTX (Group 4), CNTO 1959 + MTX (Group 5) | Janssen Research & Development, LLC | Arthritis, Rheumatoid | 12/13 | 05/14 | | |
